Compare Ascendis Pharma A/S (ASND) vs Spotify Technology (SPOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Spotify Technology — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Spotify Technology trades at $501.85 (market cap $103.00B). The key difference: Spotify Technology is far larger — about 6.2× Ascendis Pharma A/S's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Spotify Technology nearer its low. Which is the better fit depends on your goals.
| ASND | SPOT | |
|---|---|---|
Market Cap | $16.67B | $103.00B |
Sector | Health | Media |
52-Week High | $277.18 | $738.53 |
52-Week Low | $189.74 | $412.75 |
Enterprise Value | $17.04B | $92.70B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
